Literature DB >> 14639465

The NKT cell system: bridging innate and acquired immunity.

Masaru Taniguchi, Ken-Ichiro Seino, Toshinori Nakayama.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14639465     DOI： 10.1038/ni1203-1164

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  91 in total

1.  Age-related Dysregulation of Inflammation and Innate Immunity: Lessons Learned from Rodent Models.

Authors:  Aleah L Brubaker; Jessica L Palmer; Elizabeth J Kovacs
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

Review 2.  Tolerizing allergic responses in the lung.

Authors:  C M Lloyd; J R Murdoch
Journal:  Mucosal Immunol       Date:  2010-05-26       Impact factor: 7.313

Review 3.  Immunotherapeutic strategies targeting natural killer T cell responses in cancer.

Authors:  Susannah C Shissler; Dominique R Bollino; Irina V Tiper; Joshua P Bates; Roshanak Derakhshandeh; Tonya J Webb
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

Review 4.  Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.

Authors:  Hiroshi Watarai; Daisuke Yamada; Shin-ichiro Fujii; Masaru Taniguchi; Haruhiko Koseki
Journal:  Int J Hematol       Date:  2012-05-17       Impact factor: 2.490

5.  Differential TCR gene usage between WC1- and WC1+ ruminant gammadelta T cell subpopulations including those responding to bacterial antigen.

Authors:  Seth L Blumerman; Carolyn T A Herzig; Aric N Rogers; Janice C Telfer; Cynthia L Baldwin
Journal:  Immunogenetics       Date:  2006-06-24       Impact factor: 2.846

6.  Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model.

Authors:  Gourapura J Renukaradhya; Cordelia Manickam; Mahesh Khatri; Abdul Rauf; Xiangming Li; Moriya Tsuji; Gireesh Rajashekara; Varun Dwivedi
Journal:  J Clin Immunol       Date:  2010-11-02       Impact factor: 8.317

Review 7.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

8.  Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.

Authors:  R Tohn; H Blumenfeld; S M M Haeryfar; N Veerapen; G S Besra; S A Porcelli; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

Review 9.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation.

Authors:  Elizabeth E Waffarn; Christine J Hastey; Neha Dixit; Youn Soo Choi; Simon Cherry; Ulrich Kalinke; Scott I Simon; Nicole Baumgarth
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.